Thursday, March 12, 2026
Home Authors Posts by Ogkologos

Ogkologos

4165 POSTS 0 COMMENTS

FDA Approves Blinatumomab as Consolidation for CD19-positive Philadelphia Chromosome-negative B-Cell Precursor...

Ogkologos -
0

Telisotuzumab Vedotin Associated with Durable Responses in c-Met Protein–Overexpressing Non-Squamous EGFR-wild-type...

Ogkologos -
0

Screening People at High Risk for Pancreatic Cancer May Help Them...

Ogkologos -
0

EMA Recommends Extension of Therapeutic Indications for Durvalumab to Patients with...

Ogkologos -
0

FDA Grants Accelerated Approval to Epcoritamab-bysp for Relapsed or Refractory Follicular...

Ogkologos -
0

Sacituzumab Govitecan Does Not Demonstrate a Statistically Significant OS Improvement in...

Ogkologos -
0

AI-Based Score as a Selection Tool for Supplemental MRI After Negative...

Ogkologos -
0

Neoadjuvant Camrelizumab Plus Chemotherapy Demonstrate Superior pCR Compared to Chemotherapy Alone...

Ogkologos -
0

EMA Recommends to Extend Therapeutic Indications for Crizotinib in Paediatric Patients

Ogkologos -
0

Significant Intracranial Efficacy and Survival Benefits of Osimertinib in Patients with...

Ogkologos -
0
1...515253...417Page 52 of 417

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com